Measure: CMS144
Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
Measure Versions
| eMeasure Code | Measure Year | Full Version Number | Title |
|---|---|---|---|
| CMS144v12 | 2024 | 12.0.000 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| CMS144v11 | 2023 | 11 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| CMS144v10 | 2022 | 10.0.000 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| CMS144v9 | 2021 | 9.2.000 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| CMS144v8 | 2020 | 8.1.000 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| CMS144v7 | 2019 | 7.1.000 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| CMS144v6 | 2018 | 6.0.000 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
| CMS144v5 | 2017 | 5.2.000 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Description
Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) ? 40% who were prescribed beta-blocker therapy either within a 12-month period when seen in the outpatient setting OR at each hospital discharge.Guidance
Patient Group Definitions
| Group | Description | Instructions Links |
|---|---|---|
| Initial Population | All patients aged 18 years and older with two qualifying encounters during the measurement period and a diagnosis of heart failure | Webchart Instructions |
| Denominator | Equals Initial Population with a current or prior LVEF <= 40% | Webchart Instructions |
| Denominator Exclusions | Patients with a history of heart transplant or with a Left Ventricular Assist Device (LVAD) prior to the end of the outpatient encounter with Moderate or Severe LVSD | Webchart Instructions |
| Numerator | Patients who were prescribed or already taking beta-blocker therapy during the measurement period | Webchart Instructions |
| Numerator Exclusions | Not Applicable | Webchart Instructions |
| Denominator Exceptions | Documentation of medical reason(s) for not prescribing beta-blocker therapy (e.g., arrhythmia, asthma, bradycardia, hypotension, patients with atrioventricular block without cardiac pacer, observation of consecutive heart rates <50, allergy, intolerance, other medical reasons) Documentation of patient reason(s) for not prescribing beta-blocker therapy (e.g., patient declined, other patient reasons) | Webchart Instructions |
Details
| Full eMeasure Code | eMeasure Identifier | Measure Year | Version | NQF # | GUID |
|---|---|---|---|---|---|
| CMS144v11 | 144 | 2023 | 11 | 0083 | 8439f671-2932-4d4c-88ca-ea5faeacc89a |
| Steward | Developer | Endorsed By |
|---|---|---|
| American Heart Association | American Medical Association (AMA) | National Quality Forum |
| Scoring Method | Measure Type | Stratification | Risk Adjustment |
|---|---|---|---|
| Proportion | Process | None | None |
Rate Aggregation
None
Improvement Notation
Higher score indicates better qualityRationale
Clinical Recommendation Statement
Definition
Transmission Format
Applicable Value Sets
| Category | Value Set | OID |
|---|---|---|
| Allergy/Intolerance | Beta Blocker Therapy Ingredient | 2.16.840.1.113883.3.526.3.1493 |
| Diagnosis | Allergy to Beta Blocker Therapy | 2.16.840.1.113883.3.526.3.1177 |
| Diagnosis | Arrhythmia | 2.16.840.1.113883.3.526.3.366 |
| Diagnosis | Asthma | 2.16.840.1.113883.3.526.3.362 |
| Diagnosis | Atrioventricular Block | 2.16.840.1.113883.3.526.3.367 |
| Diagnosis | Bradycardia | 2.16.840.1.113883.3.526.3.412 |
| Diagnosis | Cardiac Pacer in Situ | 2.16.840.1.113883.3.526.3.368 |
| Diagnosis | Heart Failure | 2.16.840.1.113883.3.526.3.376 |
| Diagnosis | Heart Transplant Related Diagnoses | 2.16.840.1.113762.1.4.1178.56 |
| Diagnosis | Hypotension | 2.16.840.1.113883.3.526.3.370 |
| Diagnosis | Intolerance to Beta Blocker Therapy | 2.16.840.1.113883.3.526.3.1178 |
| Diagnosis | Left Ventricular Assist Device Related Diagnoses | 2.16.840.1.113762.1.4.1178.58 |
| Diagnosis | Moderate or Severe LVSD | 2.16.840.1.113883.3.526.3.1090 |
| Diagnostic Study, Performed | Ejection Fraction | 2.16.840.1.113883.3.526.3.1134 |
| Encounter, Performed | Care Services in Long-Term Residential Facility | 2.16.840.1.113883.3.464.1003.101.12.1014 |
| Encounter, Performed | Home Healthcare Services | 2.16.840.1.113883.3.464.1003.101.12.1016 |
| Encounter, Performed | Nursing Facility Visit | 2.16.840.1.113883.3.464.1003.101.12.1012 |
| Encounter, Performed | Office Visit | 2.16.840.1.113883.3.464.1003.101.12.1001 |
| Encounter, Performed | Outpatient Consultation | 2.16.840.1.113883.3.464.1003.101.12.1008 |
| Encounter, Performed | Patient Provider Interaction | 2.16.840.1.113883.3.526.3.1012 |
| Medication, Active | Beta Blocker Therapy for LVSD | 2.16.840.1.113883.3.526.3.1184 |
| Medication, Not Ordered | Beta Blocker Therapy for LVSD | 2.16.840.1.113883.3.526.3.1184 |
| Medication, Order | Beta Blocker Therapy for LVSD | 2.16.840.1.113883.3.526.3.1184 |
| Patient Characteristic Ethnicity | Ethnicity | 2.16.840.1.114222.4.11.837 |
| Patient Characteristic Payer | Payer | 2.16.840.1.114222.4.11.3591 |
| Patient Characteristic Race | Race | 2.16.840.1.114222.4.11.836 |
| Patient Characteristic Sex | ONC Administrative Sex | 2.16.840.1.113762.1.4.1 |
| Physical Exam, Performed | Heart Rate | 2.16.840.1.113883.3.526.3.1176 |
| Procedure, Performed | Cardiac Pacer | 2.16.840.1.113762.1.4.1178.53 |
| Procedure, Performed | Heart Transplant | 2.16.840.1.113762.1.4.1178.33 |
| Procedure, Performed | Left Ventricular Assist Device Placement | 2.16.840.1.113762.1.4.1178.61 |